Back to funds
View filing
Seven Fleet Capital Management LP
hedge fundUpdated 25 days agoManaged by Seven Fleet Capital Management Lp • Latest filing Q2 2026
Portfolio value
$605.9M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $131.5M |
| Q1 2026 | $315.1M |
| Q2 2026 | $605.9M |
Top holdings
114 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CGON CG ONCOLOGY INC | $102.3M | 1.44M | 16.88% | — |
| 2 | T TNGX TANGO THERAPEUTICS INC | $54.4M | 1.91M | 8.99% | — |
| 3 | T TNGX TANGO THERAPEUTICS INC | $41.2M | 1.32M | 6.80% | — |
| 4 | R RVMDW REVOLUTION MEDICINES INC | $36.4M | 194.4K | 6.01% | — |
| 5 | C CGON CG ONCOLOGY INC | $31.7M | 446.8K | 5.24% | — |
| 6 | P PHVS PHARVARIS N V | $16.7M | 482.5K | 2.75% | — |
| 7 | A AAVXF ABIVAX SA | $14.8M | 111.3K | 2.45% | — |
| 8 | E ELVN ENLIVEN THERAPEUTICS INC | $14.7M | 289.1K | 2.42% | — |
| 9 | L LQDA LIQUIDIA CORPORATION | $14.5M | 182.1K | 2.40% | — |
| 10 | M MIRM MIRUM PHARMACEUTICALS INC | $12.9M | 110.4K | 2.13% | — |
| 11 | P PHVS PHARVARIS N V | $10.1M | 292.0K | 1.67% | — |
| 12 | C CYTK CYTOKINETICS INC | $10.1M | 118.2K | 1.66% | — |
| 13 | T TSHA TAYSHA GENE THERAPIES INC | $9.9M | 1.50M | 1.64% | — |
| 14 | R RVMDW REVOLUTION MEDICINES INC | $8.9M | 47.7K | 1.47% | — |
| 15 | M MANE VERADERMICS INC | $8.6M | 70.0K | 1.42% | — |
| 16 | A AVBP ARRIVENT BIOPHARMA INC | $8.6M | 246.6K | 1.41% | — |
| 17 | A AVTX AVALO THERAPEUTICS INC | $8.1M | 438.6K | 1.34% | — |
| 18 | T TARS TARSUS PHARMACEUTICALS INC | $7.9M | 117.1K | 1.31% | — |
| 19 | X XNCR XENCOR INC | $7.8M | 368.3K | 1.29% | — |
| 20 | R ROIV ROIVANT SCIENCES LTD | $7.8M | 220.1K | 1.29% | — |